BlackRock’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $5.4M | Sell |
|
|||||
|
2022
Q1 | $12.4M | Buy |
|
|||||
|
2021
Q4 | $19M | Buy |
|
|||||
|
2021
Q3 | $38.6M | Sell |
|
|||||
|
2021
Q2 | $65.1M | Sell |
|
|||||
|
2021
Q1 | $73.1M | Buy |
|
|||||
|
2020
Q4 | $85.9M | Buy |
|
|||||
|
2020
Q3 | $91.5M | Buy |
|
|||||
|
2020
Q2 | $122M | Buy |
|
|||||
|
2020
Q1 | $106M | Sell |
|
|||||
|
2019
Q4 | $170M | Buy |
|
|||||
|
2019
Q3 | $70.2M | Buy |
|
|||||
|
2019
Q2 | $80.8M | Buy |
|
|||||
|
2019
Q1 | $60.6M | Sell |
|
|||||
|
2018
Q4 | $32M | Buy |
|
|||||
|
2018
Q3 | $46.2M | Buy |
|
|||||
|
2018
Q2 | $58.3M | Buy |
|
|||||
|
2018
Q1 | $69.2M | Sell |
|
|||||
|
2017
Q4 | $49.8M | Buy |
|
|||||
|
2017
Q3 | $64.5M | Buy |
|
|||||
|
2017
Q2 | $49.6M | Buy |
|
|||||
|
2017
Q1 | $55.2M | Buy |
|
|||||
|
2016
Q4 | $55K | Sell |
|
|||||
|
2016
Q3 | $45K | Buy |
|
|||||
|
2016
Q2 | $45K | Buy |
|
|||||
|
2016
Q1 | $38K | Buy |
|
|||||
|
2015
Q4 | $11K | Sell |
|
|||||
|
2015
Q3 | $11K | Buy |
|
|||||
|
2015
Q2 | $18K | Buy |
|
|||||
|
2015
Q1 | $6K | Hold |
|
|||||
|
2014
Q4 | $6K | Hold |
|
|||||
|
2014
Q3 | $8K | Hold |
|
|||||
|
2014
Q2 | $9K | Buy |
|
|||||
|
2014
Q1 | $4K | Buy |
|
|||||
|
2013
Q4 | $3K | Hold |
|
|||||
|
2013
Q3 | $5K | Buy |
|